Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
British Journal of Cancer|September 17, 2009
Open-label, clinical phase I studies of tasquinimod in patients with castration-resistant prostate cancerO Bratt, M Häggman, G Ahlgren, et al.
European Urology|January 1, 1994
Effects of 3 months' neoadjuvant hormonal treatment with a GnRH analogue (triptorelin) prior to radical retropubic prostatectomy on prostate-specific antigen and tumour volume in prostate cancerG Aus, S Brändstedt, M Häggman, et al.
The Prostate|September 1, 1994
Elevated expression of estramustine binding protein (EMBP) in prostatic intraepithelial neoplasia (PIN) compared with malignant and benign prostatic epitheliaM de la Torre, S Eklöv, M Häggman, et al.
Scientific Reports|October 3, 2025
Light spectrum modulates stress and defense gene expression in potato (Solanum tuberosum L.) shoot tips during post-cryopreservation recoveryJaanika Edesi, Soile Jokipii-Lukkari, Heikki M Salo, et al.
Scandinavian Journal of Urology and Nephrology|March 1, 1994
Pre- and postoperative DNA ploidy patterns correlated to pT-stage, histological grade and tumour volume in total prostatectomy specimensM Häggman, M de la Torre, S Brändstedt, et al.
European Urology|January 1, 1993
Histopathological changes in androgen-deprived localized prostatic cancer. A study in total prostatectomy specimensM Hellström, M Häggman, S Brändstedt, et al.
European Urology|January 1, 1993
Neoadjuvant GnRH-agonist treatment (triptorelin and cyproterone acetate for flare protection) and total prostatectomyM Häggman, M Hellström, G Aus, et al.
Archivos Espanoles De Urologia|February 10, 1999
[Comparison among patients considered candidates for radical prostatectomy in academic institutes in different countries]J C Angulo, A Akdas, J M Eberle, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 21, 2013
Long-term survival and biomarker correlates of tasquinimod efficacy in a multicenter randomized study of men with minimally symptomatic metastatic castration-resistant prostate cancerA J Armstrong, M Häggman, W M Stadler, et al.
Pageof 3